Day: March 22, 2021

SFL Corporation Ltd. (NYSE: SFL) (“SFL” or the “Company”) announces that its annual report on Form 20-F for the financial year ended December 31, 2020 (the “Annual Report”) has been filed with the U.S. Securities and Exchange Commission (the “Commission”). The Annual Report may be accessed through SFL’s website, www.sflcorp.com, or directly in the link below. The Annual Report is also available on the website of the Commission at www.sec.gov. Shareholders may also receive a hard copy of the Annual Report, which includes the Company’s complete 2020 audited financial statements, free of charge, by submitting the contact form requesting the report at www.sflcorp.com. March 22, 2021 The Board of DirectorsSFL Corporation Ltd.Hamilton, Bermuda Questions can be directed to SFL Management AS: Investor and Analyst Contacts:Aksel Olesen, Chief...

Reference is made to the notices on 3 March and 10 March 2021 regarding issue of shares to employees under the employee share purchase plan and to employees exercising incentive subscription rights. The capital increase has been registered and the shares issued. The company’s share capital is now NOK 137,508,072.75 divided into 916,720,485 shares each with a nominal value of NOK 0.15. For further information contact:Marianne Bøe, Investor RelationsE-mail: marianne.boe@idexbiometrics.comTel: + 47 918 00186Derek D’Antilio, Chief Financial OfficerE-mail: derek.dantilio@idexbiometrics.comTel: +1 978 273 1344Brett L Perry, Shelton GroupE-mail: bperry@sheltongroup.comTel: + 1 214 272 0070 About IDEX BiometricsIDEX Biometrics ASA (OSE: IDEX and Nasdaq: IDBA) is a leading provider of fingerprint identification technologies offering simple,...

Bagsværd, Denmark, 22 March 2021 – Novo Nordisk today announced that the US Food and Drug Administration (FDA) has issued a Refusal to File letter covering the label expansion application for once-weekly semaglutide 2.0 mg for the treatment of type 2 diabetes which was filed on 20 January 2021. A refusal to file letter is received when the FDA determines additional information is required to review a complete application. In the letter, FDA has requested additional information including data relating to a proposed new manufacturing site. While additional information needs to be included in the resubmission, Novo Nordisk believes the already completed clinical trial programme will be sufficient for approval of the label expansion application. Novo Nordisk expects to resubmit the application to FDA during the second quarter of 2021. About...

Company announcement – No. 16 / 2021 Zealand Pharma Announces FDA Approval of Zegalogue® (dasiglucagon) injection, for the Treatment of Severe Hypoglycemia in People with DiabetesZegalogue will be available in both an auto injector and a prefilled syringe for the treatment of severe hypoglycemia in patients with diabetes age 6 or older Approval based on results from three pivotal trials in adults and children with diabetes, showing median time to blood glucose recovery from severe hypoglycemia of 10 minutes following injection of 0.6 mg/0.6 mL Zegalogue Company to host conference call Tuesday, March 23 at 1:00PM CET (8:00AM ET)Copenhagen, DK and Boston, MA, U.S. March 22, 2021 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078,) a biotechnology company aspiring to deliver innovation with novel peptide therapeutics, announced today...

Vancouver, March 22, 2021 – Leading Edge Materials Corp. (“Leading Edge” or the “Company”) (TSXV: LEM) (Nasdaq First North: LEMSE) (OTCQB: LEMIF) provides a letter from the Chief Executive Officer. CEO’S LETTER TO THE SHAREHOLDERS Dear Shareholders and Stakeholders, When I was offered the opportunity to become the Chief Executive Officer of Leading Edge Materials in May last year the world had just been upended by the COVID pandemic and clean energy raw material stocks were suffering from a multi-year decline in sentiment. Today, less than 12 months later, vaccination programs are being rolled out across the globe and companies focused on raw materials that drive the transition to climate neutrality are attracting significant interest again. After an initial short-lived fall in demand and supply chain distortions momentum shifted dramatically...

DEERFIELD, Ill., March 22, 2021 (GLOBE NEWSWIRE) — Surgalign Holdings, Inc. (Nasdaq: SRGA), a global medical technology company focused on advancing spine surgery and improving patient outcomes, including through the application of digital technology, today announced that the management team will present at the Sidoti Virtual Investor Conference on Thursday, March 25, 2021. The Company is scheduled to present at the conference at 10:45 a.m. Eastern Time the same day via webcast. A live audio webcast of the conference presentation will be available online through the investor relations page of the Company’s website at surgalign.com/investors/. A replay of the webcast will be archived on the website. About Surgalign Holdings, Inc. Surgalign Holdings, Inc. is a global medical technology company advancing the science of spine care,...

TORONTO, March 22, 2021 (GLOBE NEWSWIRE) — Cryptologic Corp. (CSE:CRY) (the “Company” or “Cryptologic”) is pleased to announce that it has filed and is in the process of mailing the management information circular (the “Circular”) and related materials in connection with the annual and special meeting (the “Meeting”) of shareholders to be held on April 14, 2021. Fundamental Change At the Meeting, the Company will seek shareholder approval of, among other things, an ordinary resolution (the “Fundamental Change Resolution”) that the Company be authorized to proceed with the previously announced proposed acquisition of Copenhagen Minerals Inc. (“Copenhagen”), which owns 100% of a mineral exploration license known as the Storø Gold Project, located in Greenland (the “Proposed Acquisition”). Completion of the Proposed Acquisition would...

Vancouver, March 22, 2021 – Leading Edge Materials Corp. (“Leading Edge Materials” or the “Company”) (TSXV: LEM) (Nasdaq First North: LEMSE) (OTCQB: LEMIF) announces that its Annual General Meeting of Shareholders (the “Meeting”) will be held at Suite 1305 – 1090 West Georgia Street, Vancouver, British Columbia, V6E 3V7 on Wednesday, April 21, 2021, at 10:00 am (Vancouver Time), for the following purposes:to receive the Chief Executive Officer’s Report to the Shareholders of the Company; to receive and consider the financial statements of the Company as at and for the year ended October 31, 2020, together with the report of the auditors thereon; to fix the number of directors of the Company to be elected at the Meeting; to elect directors of the Company for the ensuing year; to appoint the auditors of the Company for the ensuing year...

Rochester Hills, Michigan, March 22, 2021 (GLOBE NEWSWIRE) —  InfuSystem Holdings, Inc. (NYSE American: INFU), (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today that Rich DiIorio, Chief Executive Officer and Barry Steele, Chief Financial Officer, will present at Sidoti’s Spring 2021 Virtual Conference at 9:15 a.m. ET on Thursday, March 25, 2021, on a virtual platform. A webcast of the presentation will be posted under the investor relations section of InfuSystem’s website at www.infusystem.com. A replay of the presentation will be available following the event. Management is scheduled to meet with investors March 24-25, with one-on-one meetings to be held throughout the two days.  Investors...

ROSEMONT, Ill., March 22, 2021 (GLOBE NEWSWIRE) — Wintrust Financial Corporation (“Wintrust”) (Nasdaq: WTFC) today announced it will release its first quarter 2021 earnings results after the market closes on Monday, April 19, 2021 and host a conference call on Tuesday, April 20, 2021 at 10:00 a.m. (CDT). Individuals interested in participating in the call should dial 877-363-5049 and enter Conference ID #3477928 or a simultaneous audio-only web cast may be accessed via the Company’s web site at http://www.wintrust.com, Investor Relations link.   An accompanying slide presentation for those participating in the call or listening via web cast will be available on the Company’s web site at http://www.wintrust.com, Investor Relations link. A replay of the audio-only webcast and an accompanying slide presentation will subsequently...